Discusses Advanced Wound Care Solutions and Data-Driven Approaches in Clinical Healing November 12, 2025 5:00 PM ...
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions (“AVITA Medical,” or the “Company”), today reported financial results ...
AVITA Medical (RCEL) announced two podium presentations at the 2025 Southern Region Burn Conference, SRBC, that collectively underscore the ...
Global evidence and real-world data demonstrate the clinical, operational, and economic impact of AVITA Medical’s RECELL System across wound types and patient populationsVALENCIA, Calif., Nov. 03, ...
Analysis of U.S. national burn registry data demonstrates 36% shorter hospital stays in adults with deep second-degree burns treated with RECELL versus traditional skin grafting More than $42,000 per ...
Kerecis highlights intact fish-skin grafts, offering clinicians sustainable, science-backed solutions for wound and tissue repair care. LAS VEGAS--(BUSINESS WIRE)--#kerecis--Kerecis, the company ...
LAS VEGAS--(BUSINESS WIRE)--Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, will present its clinically proven fish-skin graft ...
Please provide your email address to receive an email when new articles are posted on . A cell-based, gene therapy skin graft healed large chronic wounds for patients with epidermolysis bullosa. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback